Isocarboxazid Tablets

Form: Tablets

Strength: 10 mg

Reference Brands: Marplan®(US)

Category: Antipsychotropic Drugs

Isocarboxazid tablets, a monoamine oxidase inhibitor (MAOI), are FDA-approved in the U.S. for the treatment of depression, particularly in patients who have not responded to other therapies. Due to its potential for serious food and drug interactions, it carries a Boxed Warning for hypertensive crisis and serotonin syndrome. U.S. regulatory requirements include strict labeling, patient safety guides, and GMP-compliant manufacturing. In the European Union, isocarboxazid is either limited or unavailable due to safety concerns, with alternatives preferred. EU dossiers, if present, must include pharmacovigilance protocols and Risk Management Plans (RMPs). Explore sourcing options at Pharmatradz.com.